• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

No room for kinkiness in a public healthcare system.

作者信息

Dowie Jack

机构信息

Public Health and Policy Department, London School of Hygiene and Tropical Medicine, London, UK.

出版信息

Pharmacoeconomics. 2005;23(12):1203-5. doi: 10.2165/00019053-200523120-00004.

DOI:10.2165/00019053-200523120-00004
PMID:16336014
Abstract
摘要

相似文献

1
No room for kinkiness in a public healthcare system.
Pharmacoeconomics. 2005;23(12):1203-5. doi: 10.2165/00019053-200523120-00004.
2
Rises in healthcare spending: where will it end?
BMJ. 2012 Nov 1;345:e7127. doi: 10.1136/bmj.e7127.
3
Costs and determinants of privately financed home-based health care in Ontario, Canada.加拿大安大略省私人资助的居家医疗保健的成本与决定因素
Health Soc Care Community. 2008 Mar;16(2):126-36. doi: 10.1111/j.1365-2524.2007.00732.x.
4
Healthcare financing in Malaysia.马来西亚的医疗保健融资。
Asia Pac J Public Health. 2002;14(1):23-8. doi: 10.1177/101053950201400106.
5
It's the prices, stupid: why the United States is so different from other countries.关键在于价格，笨蛋：美国为何与其他国家如此不同。
Health Aff (Millwood). 2003 May-Jun;22(3):89-105. doi: 10.1377/hlthaff.22.3.89.
6
Two sides of the same coin: private healthcare providers need to stop being complacent and work with, and learn from, the public sector.
Health Serv J. 2013 Apr 12;123(6346):16-7.
7
Private and public sectors should face same rules.私营部门和公共部门应遵循相同的规则。
BMJ. 2001 Nov 10;323(7321):1090.
8
Is the Canadian health care system fiscally sustainable?加拿大的医疗保健系统在财政上是否可持续？
Int J Health Serv. 2004;34(2):229-43. doi: 10.2190/HW0X-VA0Q-F99K-EP4V.
9
Private health care expenditure and quality in Beveridge systems: cross-regional differences in the Italian NHS.贝弗里奇体系下的私人医疗保健支出与质量：意大利国民健康服务体系中的跨地区差异
Health Policy. 2015 Mar;119(3):356-66. doi: 10.1016/j.healthpol.2014.10.014. Epub 2014 Nov 1.
10
The role of physicians in controlling medical care costs and reducing waste.医生在控制医疗成本和减少浪费方面的作用。
JAMA. 2011 Aug 10;306(6):650-1. doi: 10.1001/jama.2011.1136.

引用本文的文献

1
Valuing Healthcare Goods and Services: A Systematic Review and Meta-Analysis on the WTA-WTP Disparity.评估医疗保健商品和服务：WTA-WTP 差异的系统评价和荟萃分析。
Pharmacoeconomics. 2020 May;38(5):443-458. doi: 10.1007/s40273-020-00890-x.
2
NICE: biased use of cost-effectiveness is inefficient and inequitable.英国国家卫生与临床优化研究所（NICE）：对成本效益的片面使用既无效率又不公平。
F1000Res. 2015 Oct 16;4:1078. doi: 10.12688/f1000research.7191.1. eCollection 2015.
3
Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.

本文引用的文献

1
Cost-effectiveness acceptability curves and a reluctance to lose.成本效益可接受性曲线与不愿失去的心态。
Pharmacoeconomics. 2005;23(12):1207-14. doi: 10.2165/00019053-200523120-00005.
2
Why cost-effectiveness should trump (clinical) effectiveness: the ethical economics of the South West quadrant.为何成本效益应胜过（临床）疗效：西南象限的伦理经济学
Health Econ. 2004 May;13(5):453-9. doi: 10.1002/hec.861.
3
Is there a kink in consumers' threshold value for cost-effectiveness in health care?消费者在医疗保健方面对成本效益的阈值是否存在拐点？
咪喹莫特 5%乳膏与基于甲氨基酮戊酸的光动力疗法治疗非过度角化、非肥厚性光化性（太阳）角化病的成本效益比较：决策树模型。
Pharmacoeconomics. 2010;28(11):1055-64. doi: 10.2165/11538670-000000000-00000.
4
Loss aversion and cost effectiveness of healthcare programmes: whose aversion counts anyway?医疗保健项目中的损失厌恶与成本效益：到底谁的厌恶才重要？
Pharmacoeconomics. 2008;26(11):899-900. doi: 10.2165/00019053-200826110-00002.
5
Loss aversion and cost effectiveness of healthcare programmes.医疗保健项目中的损失厌恶与成本效益
Pharmacoeconomics. 2008;26(11):895-8. doi: 10.2165/00019053-200826110-00001.
6
Economic evaluation and decision making in the UK.英国的经济评估与决策制定
Pharmacoeconomics. 2006;24(11):1133-42. doi: 10.2165/00019053-200624110-00009.
Health Econ. 2002 Mar;11(2):175-80. doi: 10.1002/hec.655.